Search Tag: cancer drugs
2019 26 Aug
Summary: Cancer affects everybody's life at some point. ‘The Death of Cancer,' written by one of oncology's leading figures, Dr Vincent T. DeVita, documents his own journey for the cure. Dr Peter Kapitein gives his personal review on the book. In 2005 I was diagnosed with lymph gland cancer and became interested in the medical industrial...Read more
2015 08 Aug
In a manifesto, a group of eminent oncologists note how the steep prices of cancer drugs are affecting the care of patients with cancer. They cite data showing that in 2014 all new FDA-approved cancer drugs were priced above $120,000 per year of use. They are calling for a reduction in drug prices. While the skyrocketing drug prices may be driving...Read more
2015 04 Feb
Access to treatment and care is the fundamental right of any patient. In cancer, despite the fast rate of new agent development, there are still astounding inequalities in the availability of and accessibility to cancer medications across Europe, according to the European Society for Medical Oncology, which is leading a European Consortium Study on...Read more
2015 23 Jan
The American Society of Clinical Oncology (ASCO) has designated four new leukaemia therapies as its cancer Advance of the Year. The announcement was made this week in ASCO’s 10th Annual Report on Progress Against Cancer, which has been published in the Journal of Clinical Oncology . New Treatments, New Hope for CLL Patients Chronic lymphocytic...Read more
2015 12 Jan
The European Medical Agency (EMA) has shown its support for a record number of orphan medicines in 2014. Out of a total of 82 medicines for human use, 17 are indicated for the treatment of a rare disease. EMA has given positive opinions on 40 new non-orphan drugs, three biosimilars, one drug for paediatric use and 21 generic, hybrid and informed consent...Read more
2014 12 Dec
According to the results of a multi-centre phase II trial presented at the 2014 San Antonio Breast Cancer Symposium, a new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer. The study is based on the work done by Doris Germain of Mt. Sinai Hospital and included 118 post-menopausal...Read more